Zimmer Biomet Holdings, Inc. Stock
Equities
ZBH
US98956P1021
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.91 USD | +1.33% |
|
+3.26% | -0.01% |
| Feb. 06 | Diary - U.S. earnings week ahead | RE |
| Feb. 05 | Bactiguard Reports Higher EBITDA | FW |
| Capitalization | 17.82B 15.09B 13.83B 13.09B 24.31B 1,615B 25.42B 161B 63.61B 777B 66.83B 65.46B 2,798B | P/E ratio 2025 * |
19.8x | P/E ratio 2026 * | 16.6x |
|---|---|---|---|---|---|
| Enterprise value | 24.31B 20.58B 18.86B 17.86B 33.16B 2,202B 34.67B 219B 86.76B 1,060B 91.16B 89.28B 3,816B | EV / Sales 2025 * |
2.96x | EV / Sales 2026 * | 2.69x |
| Free-Float |
62.74% | Yield 2025 * |
1.09% | Yield 2026 * | 1.15% |
Last Transcript: Zimmer Biomet Holdings, Inc.
| 1 day | +1.33% | ||
| 1 week | +3.26% | ||
| Current month | +3.26% | ||
| 1 month | -5.11% | ||
| 3 months | +1.58% | ||
| 6 months | -1.36% | ||
| Current year | -0.01% |
| 1 week | 85.76 |  | 90.09 |
| 1 month | 84.59 | | 94.94 |
| Current year | 84.59 | | 95.32 |
| 1 year | 84.59 | | 114.44 |
| 3 years | 84.59 | | 149.25 |
| 5 years | 84.59 | | 180.36 |
| 10 years | 74.37 | | 180.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ivan Tornos
CEO | Chief Executive Officer | 49 | 2023-08-21 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 2019-06-30 |
Nitin Goyal
CTO | Chief Tech/Sci/R&D Officer | - | 2021-06-06 |
| Director | Title | Age | Since |
|---|---|---|---|
Arthur Higgins
BRD | Director/Board Member | 69 | 2007-02-11 |
Robert Hagemann
BRD | Director/Board Member | 69 | 2008-03-12 |
Betsy Bernard
BRD | Director/Board Member | 70 | 2008-12-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -1.34% | 0.77% | 26 M€ | |
| -.--% | 0.72% | 2 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.33% | +3.26% | -12.45% | -30.04% | 17.82B | |
| +1.60% | +1.40% | -13.56% | +0.07% | 193B | |
| -0.05% | -0.06% | +13.30% | +20.72% | 132B | |
| +2.01% | +0.01% | +45.96% | +132.54% | 69.89B | |
| +1.70% | +3.21% | -7.57% | -16.05% | 59.84B | |
| -1.84% | +2.22% | +36.21% | +85.77% | 56.95B | |
| +2.38% | +7.01% | - | - | 39.36B | |
| +0.11% | -4.20% | -20.78% | -34.44% | 27.29B | |
| +3.42% | -3.98% | +11.85% | +17.48% | 24.75B | |
| -1.93% | -5.52% | -16.56% | -49.60% | 20.45B | |
| Average | +0.87% | +0.05% | +4.05% | +14.05% | 64.1B | |
| Weighted average by Cap. | +0.94% | +0.81% | +5.20% | +23.07% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 8.21B 6.95B 6.37B 6.03B 11.2B 744B 11.71B 74.01B 29.3B 358B 30.79B 30.15B 1,289B | 8.61B 7.28B 6.68B 6.32B 11.74B 780B 12.28B 77.59B 30.72B 375B 32.27B 31.61B 1,351B |
| Net income | 909M 769M 705M 668M 1.24B 82.32B 1.3B 8.19B 3.24B 39.63B 3.41B 3.34B 143B | 1.12B 948M 869M 823M 1.53B 101B 1.6B 10.1B 4B 48.85B 4.2B 4.11B 176B |
| Net Debt | 6.49B 5.49B 5.03B 4.77B 8.85B 588B 9.25B 58.47B 23.15B 283B 24.32B 23.82B 1,018B | 5.34B 4.52B 4.15B 3.93B 7.29B 484B 7.62B 48.19B 19.08B 233B 20.04B 19.63B 839B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-02-06 | 89.91 $ | +1.33% | 1,511,704 |
| 26-02-05 | 88.73 $ | +0.73% | 3,679,501 |
| 26-02-04 | 88.09 $ | +2.22% | 2,251,062 |
| 26-02-03 | 86.18 $ | -0.05% | 1,202,558 |
| 26-02-02 | 86.22 $ | -0.98% | 1,836,399 |
Delayed Quote Nyse, February 06, 2026 at 04:00 pm EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ZBH Stock
Select your edition
All financial news and data tailored to specific country editions
